Gene therapies hold the potential to stop or cure debilitating diseases by correcting errors in DNA. While that creates an intriguing investment opportunity, investors will certainly have their hands full wading through all of the hype. But there is one under-the-radar area that should prove more lucrative and relatively less risky: manufacturing.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,